Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -40439.10% is 32% above its 5-year average of -59759.22%, near the high end of its 5-year range (-239827.29%–1245.26%).
As of the fiscal period ended Tuesday, March 31, 2026. 71.50% above its 12-month average of -141904.12%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-03-31): -40439.10%.
NET PROFIT MARGIN
-40439.10%
NET PROFIT MARGIN AVG TTM
-141904.12%
NET PROFIT MARGIN AVG 3Y
-90464.85%
NET PROFIT MARGIN AVG 5Y
-59759.22%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+71.50%
CURRENT VS 3Y AVG
+55.30%
CURRENT VS 5Y AVG
+32.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-15553400.00%
vs the sector median at left
Virax Biolabs Group Limited
Market Cap
$357350.00
Net Profit Margin
-40439.10%
TTM Avg
-141904.12%
3Y Avg
-90464.85%
5Y Avg
-59759.22%
Market Cap
$381940.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
Market Cap
$242924.00
Net Profit Margin
-1422.78%
TTM Avg
-951.97%
3Y Avg
-568.57%
5Y Avg
-575.76%
Market Cap
$484571.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$530421.00
Net Profit Margin
-11016.07%
TTM Avg
-6147.48%
3Y Avg
-7604.80%
5Y Avg
-5197.06%
Market Cap
$568741.00
Net Profit Margin
-73.22%
TTM Avg
-7923.42%
3Y Avg
-4237.01%
5Y Avg
-2848.17%
Market Cap
$109777.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$96215.00
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$70876.00
Net Profit Margin
-22521.52%
TTM Avg
-14229.41%
3Y Avg
-9670.52%
5Y Avg
-6447.01%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Virax Biolabs Group Limited (VRAX) | $357350.00 | -40439.10% | -141904.12% | -90464.85% | -59759.22% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | -1422.78% | -951.97% | -568.57% | -575.76% |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| VivoSim Labs, Inc. (VIVS)vs › | $530421.00 | -11016.07% | -6147.48% | -7604.80% | -5197.06% |
| HCW Biologics Inc. (HCWB)vs › | $568741.00 | -73.22% | -7923.42% | -4237.01% | -2848.17% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109777.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Psyence Biomedical Ltd. (PBM)vs › | $96215.00 | N/A | 0.00% | 0.00% | 0.00% |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | -22521.52% | -14229.41% | -9670.52% | -6447.01% |
| Akanda Corp. (AKAN)vs › | $61819.00 | -17690.19% | -9089.88% | -5029.73% | -25219.12% |
Operating Margin
-51515.2%
Net Profit Margin
-40439.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -40439.10% |
| 2025-09-30 | -145445.96% |
| 2025-03-31 | -239827.29% |
| 2024-09-30 | -55651.67% |
| 2024-03-31 | -4784.70% |
| 2023-09-30 | -3803.47% |
| 2023-03-31 | -143301.79% |
| 2022-09-30 | -25062.69% |
| 2022-03-31 | 1245.26% |
| 2021-09-30 | 0.00% |
| 2021-03-31 | -280.03% |
| 2020-09-30 | -2453.26% |
| 2020-03-31 | -708.85% |
| 2019-09-30 | -833.22% |
